3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
19
Breast Neoplasms
18
Fallopian Tube Neoplasms
13
Neoplasm Metastasis
10
Triple Negative Breast Neoplasms
8
Prostatic Neoplasms
8
Neoplasms
7
Endometrial Neoplasms
7
Small Cell Lung Carcinoma
5
Pancreatic Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Solid Tumors
3
Neuroendocrine Tumors
3
Lymphoma, Non-Hodgkin
3
Lung Neoplasms
3
Glioma
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Osteosarcoma
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Glioblastoma
2
Ependymoma
2
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
olaparib
×
90 days
×
Clear all
No trials found.